Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Surgical Oncology

The Surgical Oncology Division at Rutgers Cancer Institute of New Jersey combines the expertise of fellowship-trained surgeons with advanced technologies to treat benign and malignant tumors with complex surgical procedures. Minimally invasive laparoscopic and robotic surgery-techniques performed by our physicians result in improved clinical outcomes and a faster recovery for patients.  Rutgers Cancer Institute  is one of the few centers in the region whose surgeons have vast expertise in managing patients’ disease through the unique treatment option called HIPEC or hyperthermic intraperitoneal chemotherapy to treat cancers that have spread to the abdominal cavity – a condition known as peritoneal metastases.  Also, as an NCI-designated Comprehensive Cancer Center, our patients are provided with access to the latest clinical trials including precision medicine and immunotherapies, some not available elsewhere.

Our surgical oncologists have disease specific expertise in routine, rare and complex cancers including: bladder cancer; brain and spine tumors; breast cancer; endocrine and neuroendocrine tumors, gastrointestinal cancers; head and neck cancers; hepatobiliary cancers; gynecologic cancers; kidney cancers; liver and bile duct cancers; melanoma and sarcomas; mesothelioma, pancreatic cancer; prostate cancer; testicular cancer; and thoracic cancers.

Faculty within the Division of Surgical Oncology conduct both clinical research and basic research. Scientists are investigating the efficacy of combination immunotherapies including oncolytic viruses, checkpoint inhibitors, and immune modulators, as well as defining the effects of viral and bacterial infections on anti-cancer immune responses. Clinical research involves the development of clinical trials including some of the pioneer studies in immunotherapy that have led to FDA approved treatments.

Working closely with healthcare team members from throughout Rutgers Cancer Institute and the Department of Surgery at Rutgers Robert Wood Johnson Medical School, our faculty members foster innovation in clinical surgical oncology care. Rutgers Cancer Institute and Robert Wood Johnson Medical School offer a two year ACGME accredited Fellowship in Complex General Surgical Oncology for board eligible general surgeons who wish to attain subspecialty certification for the practice of general surgical oncology as well as a Breast Surgery Fellowship.

 

Surgical Oncology Leadership

Alexander
H. Richard Alexander, MD, FACS
Chief Surgical Officer and
Chief, Surgical Oncology, Rutgers Cancer Institute, and
Regional Director of Surgery for Monmouth Medical Center, an RWJBH Facility
 


Breast Oncology Surgery

Blackwood
M. Michele Blackwood,
MD, FACS

Cheif, Section of Breast Surgery
Eladoumikdachi
Firas Eladoumikdachi,
MD, FACS

Surgical Oncologist
Kowzun
Maria Kowzun, MD
Surgical Oncologist

Shicha Kumar, MD, FACS
Surgical Oncologist
Potdevin
Lindsay Potdevin, MD
Surgical Oncologist


Endocrine and Neuroendocrine Tumor Surgery

Alexander
H. Richard Alexander, MD, FACS
Chief Surgical Officer and Chief, Surgical Oncology
Libutti
Steven K. Libutti, MD, FACS
Director, Rutgers Cancer Institute and Surgical Oncologist
Beninato
Toni Beninato, MD, MS, FACS
Endocrine Surgeon


Gastrointestinal Oncology Surgery

Alexander
H. Richard Alexander, MD, FACS
Chief Surgical Officer and Chief, Surgical Oncology
headshot of Dr. Daniel L. Feingold
Daniel L. Feingold, MD, FASCRS, FACS
,
Chief, Colorectal Surgery
August
David A. August, MD, FACS
Associate Director for Faculty Affairs and Surgical Oncologist 
Eskander
Mariam F. Eskander, MD, MPH
Surgical Oncologist
 
Grandhi
Miral Sadaria Grandhi, MD
Surgical Oncologist
 
In
Haejin In, MD, MPH, MBA
Surgical Oncologist
Associate Director of Diversity, Equity and Inclusion
Kennedy
Timothy J. Kennedy,
MD, MBA

Surgical Oncologist
Langan
Russell C. Langan, MD
Surgical Oncologist, Chief of Surgical Oncology & Hepatopancreatobiliary Surgery, Saint Barnabas Medical Center


Gynecologic Oncology Surgery

Headshot of Dr. Aikins

James K. Aikins Jr., MD, FACOG, FACS
Chief, Gynecologic Oncology


Alexandre Buckley de Meritens, MD
Gynecologic Oncologist
Girda
Euginia Girda, MD, FACOG
Gynecologic Oncologist
Leiser
Aliza Leiser, MD
Gynecologic Oncologist

Ruth D. Stephenson, DO, FACOG
Gynecologic Oncologist


Head and Neck Oncologic Surgery

Koshenkov

Matin Imanguli, MD, DDS
Head and Neck Surgeon/Microvascular Reconstructive Surgeon


Melanoma and Soft Tissue Oncology Surgery

Berger
Adam C. Berger, MD, FACS
Chief, Melanoma and Soft Tissue Surgical Oncology

Bahar Dasgeb, MD

Surgical Oncologist
Koshenkov
Vadim Koshenkov, MD
Surgical Oncologist
 

Thoracic Oncology Surgery

Langenfeld
John Langenfeld, MD
Co-Director, Thoracic Oncology Program
Thoracic Surgeon
Kontopidis
Ioannis Kontopidis, MD
Thoracic Surgeon


Urologic Oncology Surgery

Saum Ghodoussipour, MD
Saum Ghodoussipour, MD
, Director of the Bladder and Urothelial Cancer Program
Jang
Thomas L. Jang, MD, MPH, FACS Director of the Testicular Cancer Program; Director, Safety and Outcomes for the Division of Urology; Associate Chief of Urologic Oncology
Singer
Eric A. Singer, MD, MA Associate Chief of Urology; Director, Kidney Cancer Program


Surgical Oncology Research

Lattime
Edmund C. Lattime, PhD
Associate Director for Education and Training